Apellis Pharmaceuticals shares owned by Finepoint Capital
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Finepoint Capital
from 13F filings
Historical chart of Finepoint Capital investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Finepoint Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Finepoint Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-06-30 | $22M | 242k | 91.10 |
| 2023-03-31 | $19M | 284k | 65.96 |
| 2022-12-31 | $17M | 335k | 51.71 |
| 2022-09-30 | $18M | 266k | 68.30 |
| 2022-06-30 | $14M | 318k | 45.22 |